Gestational trophoblastic neoplasia screening: Difference between revisions
Mahshid |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gestational trophoblastic neoplasia}} | {{Gestational trophoblastic neoplasia}} | ||
{{CMG}}{{AE}}{{Sab}} | |||
==Overview== | |||
There is insufficient evidence to recommend routine screening for gestational trophoblastic neoplasia. | |||
==Screening== | |||
There is insufficient evidence to recommend routine screening for gestational trophoblastic neoplasia. | |||
==References== | ==References== | ||
Latest revision as of 22:39, 26 February 2019
Gestational trophoblastic neoplasia Microchapters |
Differentiating Gestational trophoblastic neoplasia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Gestational trophoblastic neoplasia screening On the Web |
American Roentgen Ray Society Images of Gestational trophoblastic neoplasia screening |
Directions to Hospitals Treating Gestational trophoblastic neoplasia |
Risk calculators and risk factors for Gestational trophoblastic neoplasia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for gestational trophoblastic neoplasia.
Screening
There is insufficient evidence to recommend routine screening for gestational trophoblastic neoplasia.